262 related articles for article (PubMed ID: 23844744)
1. Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.
Brisslert M; Rehnberg M; Bokarewa MI
Immunology; 2013 Dec; 140(4):421-9. PubMed ID: 23844744
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.
Magnusson M; Brisslert M; Zendjanchi K; Lindh M; Bokarewa MI
Rheumatology (Oxford); 2010 Oct; 49(10):1911-9. PubMed ID: 20547657
[TBL] [Abstract][Full Text] [Related]
3. The B cell repertoire in rheumatoid arthritis. I. Frequency of EBV-inducible circulating precursors producing autoantibodies.
Moynier M; Abderrazik M; Rucheton M; Combe B; Sany J; Brochier J
J Autoimmun; 1991 Aug; 4(4):631-49. PubMed ID: 1663752
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.
Lünemann JD; Frey O; Eidner T; Baier M; Roberts S; Sashihara J; Volkmer R; Cohen JI; Hein G; Kamradt T; Münz C
J Immunol; 2008 Jul; 181(2):991-1000. PubMed ID: 18606650
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.
Nakou M; Katsikas G; Sidiropoulos P; Bertsias G; Papadimitraki E; Raptopoulou A; Koutala H; Papadaki HA; Kritikos H; Boumpas DT
Arthritis Res Ther; 2009; 11(4):R131. PubMed ID: 19715572
[TBL] [Abstract][Full Text] [Related]
7. Latent gammaherpesvirus exacerbates arthritis through modification of age-associated B cells.
Mouat IC; Morse ZJ; Shanina I; Brown KL; Horwitz MS
Elife; 2021 Jun; 10():. PubMed ID: 34080972
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
9. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and rheumatoid arthritis.
Balandraud N; Roudier J
Joint Bone Spine; 2018 Mar; 85(2):165-170. PubMed ID: 28499895
[TBL] [Abstract][Full Text] [Related]
12. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis.
Liu R; Wu Q; Su D; Che N; Chen H; Geng L; Chen J; Chen W; Li X; Sun L
Arthritis Res Ther; 2012 Nov; 14(6):R255. PubMed ID: 23176102
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and rheumatoid arthritis.
Balandraud N; Roudier J; Roudier C
Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
[TBL] [Abstract][Full Text] [Related]
15. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles.
Fechtner S; Berens H; Bemis E; Johnson RL; Guthridge CJ; Carlson NE; Demoruelle MK; Harley JB; Edison JD; Norris JA; Robinson WH; Deane KD; James JA; Holers VM
Arthritis Rheumatol; 2022 Apr; 74(4):597-603. PubMed ID: 34605217
[TBL] [Abstract][Full Text] [Related]
16. Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study.
Svendsen AJ; Westergaard MCW; Draborg AH; Holst R; Kyvik KO; Jakobsen MA; Junker P; Houen G
Front Immunol; 2021; 12():650713. PubMed ID: 33777048
[No Abstract] [Full Text] [Related]
17. Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells.
Hoover SE; Kawada J; Wilson W; Cohen JI
J Infect Dis; 2008 Aug; 198(3):318-23. PubMed ID: 18544038
[TBL] [Abstract][Full Text] [Related]
18. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
19. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
20. Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis.
Kahan A; Kahan A; Amor B; Menkes CJ
Arthritis Rheum; 1985 Sep; 28(9):961-70. PubMed ID: 2994687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
